An interventional study of IMPROVE Program and Digital Psychoeducation Newsletters in Problematic Internet Use, sponsored by Sir Run Run Shaw Hospital. Recruiting at 2 sites in China. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-08-05.
Sponsored by Sir Run Run Shaw Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 132 studies in Motor Activity with a site in China — 41 open to participants now, 49 under way, 1 of them phase 3. Motor Activity · China.
Among the 132 studies in Motor Activity with a site in China, this one is the 12th largest by planned enrollment of the 113 interventional ones that give a count, is one of 22 that started in 2026, is one of 105 with no phase, reaches primary completion later than 40 of the 48 other live ones, and was the 105th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →41 of the 132 studies in Motor Activity with a site in China are open now. Recruiting first, the newest first:
Peking University Third Hospital · Sites in China
Ages 35–70
Yang Zhang · Sites in China
Ages 60–79
Shanghai Jiao Tong University School of Medicine · Sites in China
Ages 18–70 · Women only
Peking University People's Hospital · Sites in China
Ages 65+ · Healthy volunteers
Shanghai Zhongshan Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
132 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2005; this study’s year is marked. 22 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 113 across the 113 interventional studies, 221 across the 19 observational. Of the 58 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 132 have an industry lead sponsor. The 10 most frequent:
Sir Run Run Shaw Hospital is the lead sponsor of 136 studies on the registry; 73 are open to participants now.
Sir Run Run Shaw Hospital has 1 study filed under Motor Activity — fewer than ten, so there is no comparison to draw.
18 of the studies in Motor Activity with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07738809Capital University of Physical Education and Sports, ChinaEffects of Exercise Intervention on Sleep Quality and Emotional Problems in College Students With Depressive Symptoms | 2026-11 |
| NCT07755995Xu ShuishuiLatin Dance and Psychological Health in Primary School Children | 2026-11-30 |
| NCT07554027Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEffect of Episodic Future Thinking on Promoting Physical Activity Among Older Adults With Motoric Cognitive Risk Syndrome: A Randomized Controlled Trial | 2026-12 |
| NCT07137520Shenzhen Institutes of Advanced Technology ,Chinese Academy of SciencesThe Impact of Various Exercise Intensities on Energy Expenditure Metabolism | 2026-12 |
| NCT06570083Beijing Normal UniversityMobile-Based Intervention to Promote Physical Activity Among the Elderly | 2026-12-30 |
Add all 18 to your calendar (.ics) → With an account.
Among the 132 studies in Motor Activity with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Problematic internet use (PIU) is a growing behavioral health concern among university students. This study aims to evaluate the effectiveness and psychological mechanisms of "IMPROVE," a manualized, multimodal group-based psychotherapy. The IMPROVE program integrates cognitive-behavioral strategies with motivational elements, mindfulness training, and socially interactive exercise. In this randomized controlled trial, 600 university students with moderate to severe PIU will be randomized to either the 8-week IMPROVE intervention or an enhanced waitlist control group. The primary outcome is the change in PIU severity, assessed by the Internet Addiction Test (IAT) score, from baseline to the post-intervention endpoint (8 weeks).
Problematic internet use (PIU) has emerged as a prevalent and clinically significant behavioral health problem among university students, characterized by impaired control over online behaviors and associated psychological distress, functional impairment, and academic difficulties. It is increasingly conceptualized as a spectrum of heterogeneous behaviors (e.g., gaming, social media use, short-form video consumption) rather than a single homogeneous entity.
Although a growing body of research has examined interventions for PIU, the current evidence base remains limited by several methodological shortcomings, including small sample sizes , short intervention durations, insufficient follow-up, insufficient consideration of the heterogeneity of PIU, and a lack of theory-driven investigation into psychological mechanisms of change. Moreover, many existing interventions focus on single components (e.g., cognitive-behavioral techniques alone), while neglecting the multidimensional nature of PIU, which involves complex interactions between cognitive biases, emotion dysregulation, and anhedonia.
To address these gaps, this prospective, single-blind, parallel-group randomized controlled trial evaluates the efficacy, durability, and potential mechanisms of action of a manualized, group-based intervention-IMPROVE therapy-for treatment-seeking university students with PIU. IMPROVE therapy is designed as an integrative program that combines cognitive-behavioral strategies with motivational elements, mindfulness training, and socially interactive exercise, targeting core psychological processes implicated in the development and maintenance of PIU.
Eligible participants will be randomized in a 1:1 ratio to the IMPROVE intervention group or the enhanced waitlist control group using a centralized computer-generated allocation sequence. Participants in the IMPROVE group receive an 8-week structured group therapy consisting of one 120-minute session per week . Outcome assessments are conducted at baseline (T0), mid-intervention (Week 4, T1), post-intervention (Week 8, T2), and at follow-up time points of 1 month (T3), 3 months (T4), 6 months (T5), and 12 months (T6) after completion of the intervention.
The primary objective of the trial is to determine whether IMPROVE therapy leads to a greater reduction in PIU severity compared with the enhanced waitlist control at the end of the intervention. Accordingly, the primary outcome is PIU severity measured by the Internet Addiction Test (IAT), operationalized as the between-group difference in change in IAT total score from baseline (T0) to the post-intervention endpoint (T2).
The secondary objectives are to evaluate (1) the maintenance and durability of treatment effects across short-, medium-, and long-term follow-up periods, and (2) additional clinically relevant outcomes related to PIU. Secondary outcomes therefore include IAT scores at follow-up time points (T3-T6), rates of clinical remission defined by a prespecified IAT threshold, changes in associated psychological symptoms and functional impairment, and indicators of feasibility, adherence, and acceptability of the group-based intervention.
A core objective of this trial is to elucidate how the intervention exerts its effects. Guided by the I-PACE model, candidate psychological mediators will be assessed at baseline (T0), mid-intervention (T1), post-intervention (T2), and the 3-month follow-up (T4). Longitudinal mediation analyses will examine whether changes in maladaptive internet-related cognitions, emotion regulation difficulties, self-efficacy, anhedonia, perceived stress, mind wandering, and resilience statistically account for subsequent changes in PIU severity. Among participants reporting recent gaming, gaming-related maladaptive cognitions assessed using the C-RIGCS will also be examined.
A subset of participants of the IMPROVE intervention group will voluntarily undergo neuroimaging (fMRI) and blood sampling at T0 and T2 to explore the neurobiological correlates of therapeutic change.
Outcome assessors and data analysts will be blinded to treatment allocation to minimize assessment and analytic bias.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive IMPROVE therapy delivered in groups over 8 weeks, with 120 minutes per week (8 sessions total). The program integrates cognitive-behavioral strategies with motivational elements, mindfulness training, and socially interactive exercise. Sessions will be delivered by trained therapists using a standardized intervention manual, with regular weekly supervision to support consistency of intervention delivery.
Behavioral: IMPROVE Program
Participants will receive one standardized digital newsletter per week via WeChat during the initial 8-week intervention period (T0-T2). They will then remain on the waitlist until completion of the 3-month follow-up assessment (T4), after which they will be offered the full 8-week IMPROVE intervention.
Behavioral: Digital Psychoeducation Newsletters
A manualized, group-based, multimodal integrative psychotherapy. It integrates CBT-informed strategies, Mindfulness-Based Interventions, and Socially Interactive Exercise. Delivered over 8 weekly sessions (120 minutes each). Groups consist of 10-15 participants
Weekly newsletters pushed via WeChat containing psychoeducation on consequences of internet use and general advice for reducing screen time.
Change in Problematic Internet Use Severity (IAT Score)
Assessed using the Internet Addiction Test (IAT). Scores range from 20 to 100, with higher scores indicating greater severity. The primary endpoint is the change from baseline to post-intervention
Time frame: Baseline (T0) and Post-intervention (Week 8, T2)
Long-term Change in PIU Severity (IAT)
Assessing the maintenance of intervention effects using the Internet Addiction Test (IAT) scores during the follow-up phase.
Time frame: Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up
Participant Satisfaction and Acceptability
Participant satisfaction and acceptability will be assessed at postintervention using an adapted eight-item questionnaire based on the Client Satisfaction Questionnaire, supplemented by study-specific closed-ended items assessing overall programme quality, perceived helpfulness, needs fulfilment, willingness to recommend or participate again, satisfaction with therapist guidance, the helpfulness of individual sessions and intervention components, session length, programme duration, between-session practice burden, and group atmosphere. Item-level response distributions will be summarized descriptively.
Time frame: Post-intervention at Week 8 (T2)
Smartphone Addiction Risk (SAS-SV)
Assessed using the Smartphone Addiction Scale-Short Version (SAS-SV). Scores range from 10 to 60, with higher scores indicating higher risk of smartphone addiction.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Internet-use Disorder severity based on ICD-11 criteria (ACSID-11)
Assessed using the Assessment of Criteria for Specific Internet-use Disorders (ACSID-11). Frequency scores of four core ICD-11 diagnostic features (impaired control, increasing priority, continuation despite negative consequences, and functional impairment) will be evaluated. Scores range from 0 to 33, with higher scores indicating more severe addiction.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Internet Usage Duration
Self-reported daily usage hours. Prior to trial implementation, objective smartphone use time was removed from the secondary outcomes due to limited comparability across smartphone brands and operating systems.
Time frame: Baseline (T0), Week 4 (T1), Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up.
Craving Intensity (QSU-Brief)
Assessed using a modified Questionnaire on Smoking Urges-Brief (QSU-Brief) adapted for internet use. Scores range from 10 to 70, with higher scores indicating more severe craving.
Time frame: Baseline (T0), Week 4 (T1), Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up
Functional Impairment (BNCS Score)
Assessed using the adapted Brief Negative Consequence Scale (BNCS). Evaluates negative consequences across six domains (occupational, academic, interpersonal, etc.) on a 4-point scale. Scores range from 0 to 18, with higher scores suggesting more functional impairment.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Depressive Symptoms (PHQ-9 Score)
Assessed using the Patient Health Questionnaire-9 (PHQ-9). Scores range from 0 to 27, with higher scores indicating more severe depression.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Anxiety Symptoms (GAD-7 Score)
Assessed using the Generalized Anxiety Disorder-7 (GAD-7). Scores range from 0 to 21, with higher scores indicating more severe anxiety.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Insomnia Severity (ISI Score)
Assessed using the Insomnia Severity Index (ISI). Scores range from 0 to 28, with higher scores indicating more severe insomnia.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
ADHD Symptoms (ASRS-v1.1 Score)
Assessed using the Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist to screen for attention-deficit/hyperactivity disorder symptoms.The total score ranges from 0 to 72. Higher scores indicate greater ADHD symptom severity.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Mental Well-being (WHO-5 Index)
Assessed using the WHO-Five Well-Being Index. A 5-item measure of current mental well-being. Each item is scored from 0 to 5. The raw total score ranges from 0 to 25. Higher scores indicate better mental well-being.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Subjective Quality of Life (QOL-VAS)
Assessed using a single-item Quality of Life Visual Analog Scale (0-100), where 100 represents the best imaginable quality of life.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Physical Activity Level (IPAQ-SF)
Assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF). Measures frequency and duration of physical activity. Physical activity is expressed as metabolic equivalent task minutes per week (MET-minutes/week), derived from walking, moderate-intensity, and vigorous-intensity activities. Higher values indicate greater levels of physical activity. There is no fixed upper limit.
Time frame: Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Maladaptive Cognitions related to internet use (CAMCS)
Assessed using the Chinese Adolescents Maladaptive Cognitions Scale (CAMCS). Measures dimensions such as social comfort, distraction, and self-realization. The total score ranges from 0 to 48. Higher scores indicate greater levels of maladaptive cognitions.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Emotion Regulation Difficulties (DERS Score)
Assessed using the Difficulties in Emotion Regulation Scale (DERS-16).The total score ranges from 16 to 80. Higher scores indicate greater problems with emotion regulation.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
General Self-Efficacy (GSES Score)
Assessed using the General Self-Efficacy Scale (GSES). Measures perceived ability to cope with challenges. Items are rated on a 4-point Likert scale (1-4). The total score ranges from 10 to 40. Higher scores indicate greater perceived self-efficacy.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Anhedonia (ASA-C Score)
Assessed using the Anhedonia Scale for Adolescents-Chinese version (ASA-C) to evaluate reward processing and motivation. The total score ranges from 0 to 42. Higher scores indicate worse anhedonia.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Perceived Stress (PSS-10 Score)
Assessed using the Perceived Stress Scale (PSS-10). Measures the degree to which life situations are appraised as stressful. Total scores range from 0 to 40, with higher scores suggesting higher perceived stress.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Mind Wandering (MWQ Score)
Assessed using the Mind Wandering Questionnaire (MWQ). Measures the frequency of task-unrelated thoughts. Scores range from 5 to 30, with higher scores indicating more frequent mind wandering.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Resilience (CD-RISC-10 Score)
Assessed using the 10-item Connor-Davidson Resilience Scale (CD-RISC). Measures stress coping ability. Scores range from 0 to 40, with higher scores suggesting better resilience.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Internet gaming disorder severity (IGDS9-SF)
Gamers were additionally assessed with IGDS9-SF. Measure the severity of IGD, the only internet-related behavioral addictions that get recognized in DSM-5 and ICD-11. Scores range from 9 to 45, with higher scores suggesting more severe internet gaming disorder.
Time frame: Baseline (T0), Week 4 (T1), Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up for gamers only.
Current craving intensity (VAS)
Assessed by a single-item Visual Analogue Scale (VAS, 0-100) for current craving intensity. Higher scores indicate more severe craving.
Time frame: Baseline (T0), Week 4 (T1), Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up
Maladaptive Cognitions related to gaming (C-RIGCS)
For gamers, The Chinese version of Revised Internet Gaming Cognition Scale (C-RIGCS) were also assessed. Scores range from 0 to 60, with higher scores suggesting more severe maladaptive cognitions related to gaming.
Time frame: Baseline (T0), Mid-intervention at Week 4 (T1), Post-intervention at Week 8 (T2), and Month 3 Follow-up (T4)
Clinical Remission of Problematic Internet Use
Clinical remission is defined as an Internet Addiction Test total score below 50. Between-group comparisons will be conducted through the 3-month follow-up assessment (T4). Outcomes at T5 and T6 will be evaluated descriptively because participants in the enhanced waitlist control group will be offered the IMPROVE intervention after T4.
Time frame: Postintervention at Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6)
Collection of neuroimaging data for exploratory analyses
Structural and functional MRI data will be acquired in a voluntary substudy for exploratory, hypothesis-generating analyses. Imaging-derived metrics (e.g., regional brain measures, task-related activation, or connectivity indices) will be determined based on prespecified analytic plans developed prior to data analysis. Analyses will be restricted to consenting participants assigned to the IMPROVE intervention group and will examine within-participant changes in neuroimaging measures from T0 to T2 and their associations with clinical improvement.
Time frame: Baseline (T0) and Post-intervention at Week 8 (T2)
Collection of peripheral blood samples for exploratory biomarker analyses
Peripheral blood samples will be collected for future exploratory analyses of stress-related and inflammatory biomarkers. Analyses will be restricted to consenting participants assigned to the IMPROVE intervention group and will examine within-participant changes in peripheral biological measures from T0 to T2 and their associations with clinical improvement.
Time frame: Baseline (T0) and Post-intervention at Week 8 (T2)
Plan to share: Yes — Deidentified individual participant data underlying the results reported in the primary and secondary trial publications, together with a data dictionary, will be made available upon reasonable request. Data will be available beginning after publication of the primary trial results and for 5 years. Requests must include a scientifically sound research proposal and statistical analysis plan and will be reviewed by the principal investigator and study team. Access will be subject to participant consent, applicable ethical and data-protection requirements, and execution of a data-use agreement. Approved data will be provided only for the analyses specified in the accepted proposal.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Beginning immediately after publication of the primary trial results and ending 5 years thereafter.
Access criteria: Researchers seeking access should submit a methodologically sound research proposal and statistical analysis plan to the principal investigator. Requests will be evaluated on the basis of scientific merit, feasibility, consistency with participant consent, and compliance with applicable ethical and data-protection requirements. Approved requesters will be required to sign a data-use agreement, and the data may be used only for the analyses specified in the approved proposal.
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Jun 2027, 15 months after the start.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 15 months is below that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.